Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 224

1.

Morphologic and immunophenotypic features of a case of acute monoblastic leukemia with unusual positivity for Glycophorin-A.

Carulli G, Sammuri P, Domenichini C, Rousseau M, Ottaviano V, Ferreri MI, AzzarĂ  A, Caracciolo F, Petrini M.

Hematol Rep. 2018 Dec 12;10(4):7823. doi: 10.4081/hr.2018.7823. eCollection 2018 Nov 6.

2.

Pulmonary embolism in a patient with neuroleptic malignant syndrome.

Almegren M.

Hematol Rep. 2018 Dec 12;10(4):7753. doi: 10.4081/hr.2018.7753. eCollection 2018 Nov 6.

3.

Transfusion-associated graft-versus-host disease: A concise review.

Manduzio P.

Hematol Rep. 2018 Nov 6;10(4):7724. doi: 10.4081/hr.2018.7724. eCollection 2018 Nov 6.

4.

Immunosuppression-associated posterior reversible encephalopathy syndrome in an acute leukemia case.

Malkan UY, Gunes G, Demiroglu H, Goker H.

Hematol Rep. 2018 Nov 6;10(4):7257. doi: 10.4081/hr.2018.7257. eCollection 2018 Nov 6.

5.

NOTCH activation promotes glycosyltransferase expression in human myeloid leukemia cells.

Wang S, Itoh M, Shiratori E, Ohtaka M, Tohda S.

Hematol Rep. 2018 Sep 24;10(3):7576. doi: 10.4081/hr.2018.7576. eCollection 2018 Sep 5.

6.

An adult case of atypical hemolytic uremic syndrome presented with posterior reversible encephalopathy syndrome: Successful response to late-onset eculizumab treatment.

Medeni SS, Namdaroglu S, Cetintepe T, Ozlu C, Tasli F, Adibelli ZH, Bilgir O, Tatar E.

Hematol Rep. 2018 Sep 24;10(3):7553. doi: 10.4081/hr.2018.7553. eCollection 2018 Sep 5.

7.

Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?

Lugito NPH, Kurniawan A, Kurniawan YC, Yacobus E, Halim E.

Hematol Rep. 2018 Sep 24;10(3):7394. doi: 10.4081/hr.2018.7394. eCollection 2018 Sep 5.

8.

Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver.

Nguyen AL, Kamal M, Raghavan R, Nagaraj G.

Hematol Rep. 2018 Sep 24;10(3):7235. doi: 10.4081/hr.2018.7235. eCollection 2018 Sep 5.

9.

Human hemoglobin G-Makassar variant masquerading as sickle cell anemia.

Mohamad AS, Hamzah R, Selvaratnam V, Yegapan S, Sathar J.

Hematol Rep. 2018 Sep 24;10(3):7210. doi: 10.4081/hr.2018.7210. eCollection 2018 Sep 5.

10.

The progression of severe aplastic anemia to hypoplastic leukemia in a long-term observation after the administration of pegylated rHuMGDF.

Ishikawa M, Matsuda A, Okamura D, Maeda T, Kawai N, Asou N, Bessho M.

Hematol Rep. 2018 Sep 5;10(3):7679. doi: 10.4081/hr.2018.7679. eCollection 2018 Sep 5.

11.

Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases.

Vanegas YAM, Azzouqa AM, Menke DM, Foran JM, Vishnu P.

Hematol Rep. 2018 Sep 5;10(3):7658. doi: 10.4081/hr.2018.7658. eCollection 2018 Sep 5.

12.

The role of red cell distribution width in the differential diagnosis of iron deficiency anemia and non-transfusiondependent thalassemia patients.

Piriyakhuntorn P, Tantiworawit A, Rattanathammethee T, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L.

Hematol Rep. 2018 Sep 5;10(3):7605. doi: 10.4081/hr.2018.7605. eCollection 2018 Sep 5.

13.

Long-term complete remission of early hematological relapse after discontinuation of immunosuppressants following allogeneic transplantation for Sezary syndrome.

Hosoi H, Hatanaka K, Murata S, Mushino T, Kuriyama K, Nishikawa A, Hanaoka N, Tamura S, Nakakuma H, Sonoki T.

Hematol Rep. 2018 Sep 5;10(3):7497. doi: 10.4081/hr.2018.7497. eCollection 2018 Sep 5.

14.

Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia.

Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Hotta M, Yoshimura H, Ishii K, Ito T, Nomura S.

Hematol Rep. 2018 Sep 5;10(3):7474. doi: 10.4081/hr.2018.7474. eCollection 2018 Sep 5.

15.

Acquired hemophilia A developing cerebral infarction 36 days after the frequent administration of bypass hemostatic agents.

Saito M, Senjo H, Kanaya M, Izumiyama K, Mori A, Tanaka M, Morioka M, Ieko M.

Hematol Rep. 2018 Sep 5;10(3):7453. doi: 10.4081/hr.2018.7453. eCollection 2018 Sep 5.

16.

Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease.

Telfer P, Agodoa I, Fox KM, Burke L, Mant T, Jurek M, Tonda M, Lehrer-Graiwer J.

Hematol Rep. 2018 May 22;10(2):7643. doi: 10.4081/hr.2018.7643. eCollection 2018 May 14.

17.

Generalized lymphadenopathy secondary to isolated extramedullary hematopoiesis as an initial manifestation of primary myelofibrosis.

Aljabry MS, Asiri S, Elsafi T, Elyamany G.

Hematol Rep. 2018 May 15;10(2):7588. doi: 10.4081/hr.2018.7588. eCollection 2018 May 14.

18.

The shortcut strategy for beta thalassemia prevention.

Suwannakhon N, Pongsawatkul K, Seeratanachot T, Mahingsa K, Pingyod A, Bumrungpakdee W, Sanguansermsri T.

Hematol Rep. 2018 May 25;10(2):7530. doi: 10.4081/hr.2018.7530. eCollection 2018 May 14.

19.

Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia.

Hotta M, Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Konishi A, Yoshimura H, Ito T, Ishii K, Nomura S.

Hematol Rep. 2018 May 16;10(2):7527. doi: 10.4081/hr.2018.7527. eCollection 2018 May 14.

20.

GBT440 reverses sickling of sickled red blood cells under hypoxic conditions in vitro.

Dufu K, Oksenberg D.

Hematol Rep. 2018 May 14;10(2):7419. doi: 10.4081/hr.2018.7419. eCollection 2018 May 14.

Supplemental Content

Loading ...
Support Center